Sulfur-containing amino acids and glutathione in diseases

Metabolic and Therapeutic Aspects of Amino Acids in Clinical Nutrition, Second Edition

Volumn , Issue , 2003, Pages 667-687

  Obled, Christiane ^a   Papet, Isabelle ^a   Breuillé, Denis ^b  

^a CEMAGREF   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85049622583     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (164)

1. Vina, J. et al., L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency, Am. J. Clin. Nutr., 61, 1067, 1995.
2. Hiramatsu, T. et al., Methionine and cysteine kinetics at different intakes of cystine in healthy adult men, Am. J. Clin. Nutr., 60, 525, 1994.
3. MacCoss, M.J., Fukagawa, N.K., and Matthews, D.E., Measurement of intracellular sulfur amino acid metabolism in humans, Am. J. Physiol., 280, E947, 2001.
4. Blom, H.J., et al., Transamination of methionine in humans, Clin. Sci., 76, 43, 1989.
5. Finkelstein, J.D., Methionine metabolism in mammals, J. Nutr. Biochem., 1, 228, 1990.
6. Stipanuk, M.H., Metabolism of sulfur-containing amino acids, Annu. Rev. Nutr., 6, 179, 1986.
7. Malinow, M.R., Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases, J. Nutr., 126, 1238S, 1996.
8. Finkelstein, J.D. and Martin, J.J., Methionine metabolism in mammals: distribution of homocysteine between competing pathways, J. Biol. Chem., 259, 9508, 1984.
9. Fukagawa, N.K., Ajami, A.M., and Young, V.R., Plasma methionine and cysteine kinetics in response to an intravenous glutathione infusion in adult humans, Am. J. Physiol., 270, E209, 1996.
10. Raguso, C.A., Regan, M.M., and Young, V.R., Cysteine kinetics and oxidation at different intakes of methionine and cystine in young adults, Am. J. Clin. Nutr., 71, 491, 2000.
11. Stipanuk, M.H. and Benevenga, N.J., Effect of cystine on the metabolism of methionine in rats, J. Nutr., 107, 1455, 1977.
12. 3]methionine kinetics in humans: methionine conservation and cystine sparing, Am. J. Physiol., 258, E790, 1990.
13. Garcia, R.A.G. and Stipanuk, M.H., The splanchnic organs, liver and kidney have unique roles in the metabolism of sulfur amino acids and their metabolites in rats, J. Nutr., 122, 1693, 1992.
14. Stipanuk, M.H. et al., Cysteine concentration regulates cysteine metabolism to glutathione, sulfate and taurine in rat hepatocyte, J. Nutr., 122, 420, 1992.
15. Bella, D.L., Kwon, Y.H., and Stipanuk, M.H., Variations in dietary protein but not in dietary fat plus cellulose or carbohydrate levels affect cysteine metabolism in rat isolated hepatocytes, J. Nutr., 126, 2179, 1996.
16. Bella, D.L. and Stipanuk, M.H., Effects of protein, methionine, or chloride on acid-base balance and on cysteine catabolism, Am. J Physiol., 269, E910, 1995.
17. Meister, A. and Anderson, M.E., Glutathione, Annu. Rev. Biochem., 52, 711, 1983.
18. Deneke, S.M. and Fanburg, B.L., Regulation of cellular glutathione, Am. J. Physiol., 257, L163, 1989.
19. Meister, A., Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy, Pharmacol. Ther., 51, 155, 1991.
20. Lauterburg, B.H., Adams, J.D., and Mitchell, J.R., Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover, Hepatology, 4, 586, 1984.
21. Pullar, J.M., Vissers, M.C.M., and Winterbourn, C.C., Glutathione oxidation by hypochlorous acid in endothelial cells produces glutathione sulfonamide as a major product but not glutathione disulfide, J. Biol. Chem., 276, 22120, 2001.
22. Hinchman, C.A. and Ballatori, N., Glutathione conjugation and conversion to mercapturic acids can occur as an intrahepatic process, J. Toxicol. Environ. Health, 41, 387, 1994.
23. White, A.C., Thannickal, V.J., and Fanburg, B.L., Glutathione deficiency in human disease, J. Nutr. Biochem., 5, 218, 1994.
24. Taylor, C.G., Nagy, L.E., and Bray, T.M., Nutritional and hormonal regulation of glutathione homeostasis, in Current Topics in Cellular Regulation, Stadtman, E.R. and Chock, P.B., Eds., Academic Press, New York, 1996, p. 189.
25. Cho, E.S., Sahyoun, N., and Stegink, L.D., Tissue glutathione as a cyst(e)ine reservoir during fasting and refeeding of rats, J. Nutr., 111, 914, 1981.
26. Hum, S., Koski, K.G., and Hoffer, L.J., Varied protein intake alters glutathione metabolism in rats, J. Nutr., 122, 2010, 1992.
27. Jahoor, F. et al., Protein-deficient pigs cannot maintain reduced glutathione homeostasis when subjected to the stress of inflammation, J. Nutr., 125, 1462, 1995.
28. Hunter, E.A.L. and Grimble, R.F., Dietary sulfur amino acid adequacy influences glutathione synthesis and glutathione dependent enzymes during the inflammatory response to endotoxin and tumour necrosis factor-alpha in rats, Clin. Sci., 92, 297, 1997.
29. Reid, M. et al., In vivo rates of erythrocyte glutathione synthesis in children with severe protein-energy malnutrition, Am. J. Physiol., 278, E405, 2000.
30. Tateishi, N. et al., Relative contributions of sulfur atoms of dietary cysteine and methionine to rat liver glutathione and proteins, J. Biochem., 90, 1603, 1981.
31. Coloso, R.M., Hirschberger, L.L., and Stipanuk, M.H., Uptake and metabolism of L-2-oxo-[35S]thiazolidine-4-carboxylate by rat cells is slower than that of L-[35S]cysteine or L-[35S]methionine, J. Nutr., 121, 1341, 1991.
32. Yu, Y.M. et al., Plasma L-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans, Am. J. Physiol., 282, E247, 2002.
33. Lyons, J. et al., Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet, Proc. Natl. Acad. Sci. U.S.A., 97, 5071, 2000.
34. Jahoor, F. et al., Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate, Am. J. Physiol., 276, E205, 1999.
35. Faber, P. et al., The effect of rate of weight loss on erythrocyte glutathione concentration and synthesis in healthy obese men, Clin. Sci., 102, 569, 2002.
36. Capitan, P. et al., Gas chromatographic-mass spectrometric analysis of stable isotopes of cysteine and glutathione in biological samples, J. Chromatogr. B, 732, 127, 1999.
37. Potter, D.W. and Tran, T.B., Apparent rates of glutathione turnover in rat tissues, Toxicol. Appl. Pharmacol., 120, 186, 1993.
38. Mansoor, M.A., Svardal, A.M., and Ueland, P.M., Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma, Anal. Biochem., 200, 218, 1992.
39. Mills, B.J. and Lang, C.A., Differential distribution of free and bound glutathione and cyst(e)ine in human blood, Biochem. Pharmacol., 52, 401, 1996.
40. Rossi, R. et al., Blood glutathione disulfide: in vivo factor or in vitro artifact? Clin. Chem., 48, 742, 2002.
41. Luo, J.L. et al., Skeletal muscle glutathione after surgical trauma, Ann. Surg., 223, 420, 1996.
42. Neuschwander-Tetri, B.A. and Rozin, T., Diurnal variability of cysteine and glutathione content in the pancreas and liver of the mouse, Comp. Biochem. Physiol. B., 114, 91, 1996.
43. Sido, B. et al., Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease, Gut, 42, 485, 1998.
44. Malmezat, T. et al., Glutathione turnover is increased during the acute phase of sepsis in rats, J. Nutr., 130, 1239, 2000.
45. Deneke, S.M., Lynch, B.A., and Fanburg, B.L., Effects of low protein diets or feed restriction on rat lung glutathione and oxygen toxicity, J. Nutr., 115, 726, 1985.
46. Märtensson, J., Jain, A., and Meister, A., Glutathione is required for intestinal function, Proc. Natl. Acad. Sci. U.S.A., 87, 1715, 1990.
47. Dröge, W. and Breitkreutz, R., Glutathione and immune function, Proc. Nutr. Soc., 59, 595, 2000.
48. Robinson, M.K. et al., Glutathione depletion in rats impairs T-cell and macrophage immune function, Arch. Surg., 128, 29, 1993.
49. Suthanthiran, M. et al., Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigen, Proc. Natl. Acad. Sci. U.S.A., 87, 3343, 1990.
50. Hammond, C.L., Lee, T., and Ballatori, N., Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes, J. Hepatol., 34, 946, 2001.
51. Lander, H.M., An essential role for free radicals and derived species in signal transduction, FASEB J., 11, 118, 1997.
52. Mosharov, E., Cranford, M.R., and Banerjee, R., The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes, Biochemistry, 39, 13005, 2000.
53. Deplancke, B. and Gaskins, H.R., Redox control of the transsulfuration and glutathione biosynthesis pathways, Curr. Opin. Clin. Nutr. Metab. Care, 5, 85, 2002.
54. Ginn-Pease, M.E. and Whisler, R.L., Redox signals and NF-kappa B activation in T cells, Free Radic. Biol. Med., 25, 346, 1998.
55. May, M.J. and Ghosh, S., Signal transduction through NF-kappa B, Immunol. Today, 19, 80, 1998.
56. Renard, P. et al., Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation, Biochem. Pharmacol., 53, 149, 1997.
57. Sen, C.K. et al., Glutathione regulation of tumor necrosis factor-alpha induced NF-kappa B activation in skeletal muscle derived L6 cells, Biochem. Biophys. Res. Commun., 237, 645, 1997.
58. Hirota, K. et al., Distinct roles of thioredoxin in the cytoplasm and in the nucleus A twostep mechanism of redox regulation of transcription factor NF-KappaB, J. Biol. Chem., 274, 27891, 1999.
59. Mallis, R.J. et al., Irreversible thiol oxidation in carbonic anhydrase III: protection by S-glutathiolation and detection in aging rats. Biol. Chem., 383, 649, 2002.
60. Thomas, J.A. and Mallis, R.J., Aging and oxidation of reactive protein sulfhydryls, Exp. Gerontol., 36, 1519, 2001.
61. Dafré, A.L., Sies, H., and Akerboom, T., Protein S-thiolation and regulation of microsomal glutathione transferase activity by the glutathione redox couple, Arch. Biochem. Biophys., 332, 288, 1996.
62. Jahngen-Hodge, J. et al., Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress, J. Biol. Chem., 272, 28218, 1997.
63. Davies, K.J.A., Degradation of oxidized proteins by the 20S proteasome, Biochimie, 83, 301, 2001.
64. Pineda-Molina, E. et al., Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding, Biochemistry, 40, 14134, 2001.
65. Rouzer, C.A. et al., Arachidonic acid metabolism in glutathione-deficient macrophages, Proc. Natl. Acad. Sci. U.S.A., 79, 1621, 1982.
66. Dale, G. et al., The effect of surgical operation on venous plasma free amino acids, Surgery, 81, 295, 1977.
67. Sax, H.C. et al., Amino acid uptake in isolated, perfused liver: effect of trauma and sepsis J. Surg. Res., 45, 50, 1988.
68. Jeevanandam, M. et al., Aminoaciduria of severe trauma, Am. J. Clin. Nutr., 49, 814, 1989.
69. Vente, J.P. et al., Plasma-amino acid profiles in sepsis and stress, Ann. Surg., 209, 57, 1989.
70. Malmezat, T. et al., Methionine transsulfuration is increased during sepsis in rats, Am. J. Physiol., 279, E1391, 2000.
71. Vina, J.R. et al., Blood sulfur-amino acid concentration reflects an impairment of liver transsulfuration pathway in patients with acute abdominal inflammatory processes, Br. J. Nutr., 85, 173, 2001.
72. Rooyackers, O.E. et al., Prolonged changes in protein and amino acid metabolism after zymosan treatment in rats, Clin. Sci., 87, 619, 1994.
73. Freund, H. et al., Plasma amino acid as predictors of the severity and outcome of sepsis, Ann. Surg., 190, 571, 1979.
74. Lyons, J. et al., Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients, Crit. Care Med., 29, 870, 2001.
75. Mercier, S. et al., Chronic inflammation alters protein metabolism in several organs of adult rats, J. Nutr., 132, 1921, 2002.
76. Luo, J.L. et al., Surgical trauma decreases glutathione synthetic capacity in human skeletal muscle tissue, Am. J. Physiol., 275, E359, 1998.
77. Chawla, R.K. et al., Plasma concentrations of transsulfuration pathway products during nasoenteral and intravenous hyperalimentation of malnourished patient, Am. J. Clin. Nutr., 42, 577, 1985.
78. Tribble, D.L. et al., Hypercysteinemia and delayed sulfur excretion in cirrhotics after oral cysteine loads, Am. J. Clin. Nutr., 50, 1401, 1989.
79. Holecek, M., Mraz, J., and Tilser, I., Plasma amino acids in four models of experimental liver injury in rats, Amino Acids, 10, 229, 1996.
80. Miura, K. et al., Cystine uptake and glutathione level in endothelial cells exposed to oxidative stress, Am. J. Physiol., 262, C50, 1992.
81. Rahman, I. et al., Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress, Am. J. Physiol., 269, L285, 1995.
82. Lang, C.A. et al., Blood glutathione decreases in chronic diseases, J. Lab. Clin. Med., 135, 402, 2000.
83. Obled, C., Papet, I., and Breuillé, D., Metabolic bases of amino acid requirements in acute diseases, Curr. Opin. Clin. Nutr. Metab. Care, 5, 189, 2002.
84. Ikegami, K. et al., Comparison of plasma reduced glutathione and oxidized glutathione with lung and liver tissue oxidant and antioxidant activity during acute inflammation, Shock, 1, 307, 1994.
85. Hammarqvist, F. et al., Skeletal muscle glutathione is depleted in critically ill patients, Crit. Care Med., 25, 78, 1997.
86. Ruan, E.A. et al., Glutathione levels in chronic inflammatory disorders of the human colon, Nutr. Res., 17, 463, 1997.
87. Miralles-Barrachina, O. et al., Low levels of glutathione in endoscopic biopsies of patients with Crohn’s colitis: the role of malnutrition, Clin. Nutr., 18, 313, 1999.
88. Breuillé, D. et al., Assessment of tissue glutathione status during experimental sepsis, Clin. Nutr., 13, 5, 1994.
89. Colomb, V. et al., Influence of antibiotics and food intake on liver glutathione and cytochrome P-450 in septic rats, Br. J. Nutr., 73, 99, 1995.
90. Keller, G.A. et al., Decreased hepatic glutathione levels in septic shock, Arch. Surg., 120, 941, 1985.
91. Reichard, S.M. and Bailey, N.M., Alterations in tissue glutathione levels following traumatic shock, Adv. Shock Res., 5, 37, 1981.
92. Yu, Y.M., Burke, J.F., and Young, V.R., A kinetic study of L-2H3-methyl-1-13C-methionine in patients with severe burn injury, J. Trauma, 35, 1, 1993.
93. Mansoor, O. et al., Albumin and fibrinogen syntheses increase while muscle protein synthesis decreases in head-injured patients, Am. J. Physiol., 273, E898, 1997.
94. Bianchi, G. et al., Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis, Metabolism, 49, 1434, 2000.
95. Breuillé, D. et al., Increased cysteine requirement induced by sepsis, Clin. Nutr., 15, 21, 1996.
96. Malmezat, T. et al., Metabolism of cysteine is modified during the acute phase of sepsis in rats. J. Nutr., 128, 97, 1998.
97. Wright, C.E. et al., Taurine: biological update, Annu. Rev. Biochem., 55, 427, 1986.
98. Bremner, I. and Beattie, J.H., Copper and zinc metabolism in health and disease: speciation and interactions, Proc. Nutr. Soc., 54, 489, 1995.
99. Bremner, I. et al., Effects of changes in dietary zinc, copper and selenium supply and of endotoxin administration on metallothionein I concentrations in blood cells and urine in the rat, J. Nutr., 117, 1595, 1987.
100. Abe, S. et al., Metallothionein and zinc metabolism in endotoxin shock rats, Experientia, Suppl. 52, 587, 1987.
101. Reeds, P.J., Fjeld, C.R., and Jahoor, F., Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J. Nutr., 124, 906, 1994.
102. Robinson, M.K. et al., Glutathione deficiency increases organ dysfunction after hemorrhagic shock, Surgery, 112, 140, 1992.
103. Bjelton, L. and Fransson, G.B., Availability of cysteine and of L-2-oxo-thiazolidine-4-carboxylic acid as a source of cysteine in intravenous nutrition, J. Parenter. Enteral. Nutr., 14, 177, 1990.
104. Coloso, R.M., Drake, M.R., and Stipanuk, M.H., Effect of bathocuproine disulfonate, a copper chelator, on cyst(e)ine metabolism by freshly isolated rat hepatocytes, Am. J. Physiol., 259, E443, 1990.
105. Stehle, P. et al., In vivo utilization of cystine-containing synthetic short-chain peptides after intravenous bolus injection in the rat, J. Nutr., 118, 1470, 1988.
106. Micke, P. et al., Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients, Eur. J. Clin. Invest., 31, 171, 2001.
107. Hagen, T.M. and Jones, D.P., Transepithelial transport of glutathione in vascularly perfused small intestine of rat, Am. J. Physiol., 252, G607, 1987.
108. Witschi, A. et al., The systemic availability of oral glutathione, Eur. J. Clin. Pharmacol., 43, 667, 1992.
109. Favilli, F. et al., Effect of orally administered glutathione on glutathione levels in some organs of rats: role of specific transporters, Br. J. Nutr., 78, 293, 1997.
110. Aebi, S., Assereto, R., and Lauterburg, B.H., High-dose intravenous glutathione in man: pharmacokinetics and effects on cyst(e)ine in plasma and urine, Eur. J. Clin. Invest., 21, 103, 1991.
111. Robinson, M.K., et al., Parenteral glutathione monoester enhances tissue antioxidant stores, J. Parenter. Enteral Nutr., 16, 413, 1992.
112. Puri, R.N. and Meister, A., Transport of glutathione, as gamma-glutamylcysteinylglycyl ester, into liver and kidney, Proc. Natl. Acad. Sci. U.S.A., 80, 5258, 1983.
113. Meister, A., Anderson, M.E., and Hwang, O., Intracellular cysteine and glutathione delivery systems, J. Am. Coll. Nutr., 5, 137, 1986.
114. Porta, P. et al., L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human, J. Pharmacol. Exp. Ther., 257, 331, 1991.
115. Jain, A. et al., L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet, J. Nutr., 125, 851, 1995.
116. Cotgreave, I.A. et al., Gastrointestinal metabolism of N-acetylcysteine in the rat, including an assay for sulfite in biological systems, Biopharm. Drug Dispos., 8, 377, 1987.
117. Sjodin, K. et al., Metabolism of N-acetyl-L-cysteine: some structural requirements for the deacetylation and consequences for the oral bioavailability, Biochem. Pharmacol., 38, 3981, 1989.
118. Yamauchi, A. et al., Tissue distribution of and species differences in deacetylation of N-acetyl-L-cysteine and immunohistochemical localization of acylase I in the primate kidney, J. Pharm. Pharmacol., 54, 205, 2002.
119. Phelps, D.T. et al., Elevation of glutathione levels in bovine pulmonary artery endothelial cells by N-acetylcysteine, Am. J. Respir. Cell Mol. Biol., 7, 293, 1992.
120. Banks, M.F. and Stipanuk, M.H., The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine, J. Nutr., 124, 378, 1994.
121. Olsson, B. et al., Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine, Eur. J. Clin. Pharmacol., 34, 77, 1988.
122. Burgunder, J.M., Varriale, A., and Lauterburg, B.H., Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration, Eur. J. Clin. Pharmacol., 36, 127, 1989.
123. Neuhauser, M. et al., Utilization of methionine and N-acetyl-L-cysteine during long-term parenteral nutrition in the growing rat, Metabolism, 35, 869, 1986.
124. Dröge, W., Cysteine and glutathione in catabolic conditions and immunological dysfunction, Curr. Opin. Clin. Nutr. Metab. Care, 2, 227, 1999.
125. Anderson, S.A. and Raiten, D.J., Eds., Safety of Amino Acids Used as Dietary Supplements, FDA Report, Life Sciences Research Office, FASEB, Bethesda, MD, 1992, p. 140.
126. Harper, A.E., Benevenga, N.J., and Wohlhueter, R.M., Effects of ingestion of disproportionate amounts of amino acids, Physiol. Rev., 50, 428, 1970.
127. Breuillé, D. et al., Differential effect of dietary supplementation with cysteine or cystine or methionine on liver glutathione concentration in septic rats, Clin. Nutr., 17, 66, 1998.
128. Luthen, R. et al., Beneficial effects of L-2-oxothiazolidine-4-carboxylate on cerulein pancreatitis in mice, Gastroenterology, 112, 1681, 1997.
129. Dröge, W. and Holm, E., Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction, FASEB J., 11, 1077, 1997.
130. De Quay, B., Malinverni, R., and Lauterburg, B.H., Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine, AIDS, 6, 815, 1992.
131. Witschi, A. et al., Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS, AIDS Res. Hum. Retroviruses, 11, 141, 1995.
132. De Rosa, S.C. et al., N-acetylcysteine replenishes glutathione in HIV infection, Eur. J. Clin. Invest., 30, 915, 2000.
133. Barditch-Crovo, P. et al., A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus, J. Clin. Pharmacol., 38, 357, 1998.
134. Bernard, G.R. et al., A trial of antioxidants N-acetylcysteine and procysteine in ARDS: the Antioxidant in ARDS Study Group, Chest, 112, 164, 1997.
135. Meyer, A. et al., Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals, Am. J. Respir. Crit. Care Med., 152, 1055, 1995.
136. Badaloo, A. et al., Cysteine supplementation improves the erythrocyte glutathione synthesis rate in children with severe edematous malnutrition, Am. J. Clin. Nutr., 76, 646, 2002.
137. Pena, L.R., Hill, D.B., and McClain, C.J., Treatment with glutathione precursor decreases cytokine activity, J. Parenter. Enter. Nutr., 23, 1, 1999.
138. Akerlund, B. et al., Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: a doubleblind placebo-controlled trial, Eur. J. Clin. Pharmacol., 50, 457, 1996.
139. Herzenberg, L.A. et al., Glutathione deficiency is associated with impaired survival in HIV disease, Proc. Natl. Acad. Sci. U.S.A., 94, 1967, 1997.
140. Breuillé, D. et al., Cysteine requirement is increased in ICU patients, Clin. Nutr., 20, 43, 2001.
141. Mansoor, O. et al., Amino acid supplementation improves muscle protein synthesis in ICU patients, Clin. Nutr., 20, 53, 2001.
142. Breuillé, D. et al., Beneficial effect of cysteine supplementation in response to sepsis, Clin. Nutr., 16, 17, 1997.
143. Ikemoto, M. et al., Cysteine supplementation prevents unweighting-induced ubiquitination in association with redox regulation in rat skeletal muscle, Biol. Chem., 383, 715, 2002.
144. Shibanuma, M., Kuroki, T., and Nose, K., Inhibition by N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF kappa B by tumor necrosis factor alpha in a mouse fibroblastic cell line, balb/3T3, FEBS Lett., 353, 62, 1994.
145. Neuschwander-Tetri, B.A. et al., Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer, Biochem. J., 320, 1005, 1996.
146. Antonicelli, F. et al., Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NFkappa B nuclear binding in alveolar epithelial cells, Free Radic. Biol. Med., 32, 492, 2002.
147. Haddad, J.J., Saade, N.E., and Safieh-Garabedian, B., Redox regulation of TNF-alpha biosynthesis: augmentation by irreversible inhibition of gamma-glutamylcysteine synthetase and the involvement of an I kappa B-alpha/NF-kappa B-independent pathway in alveolar epithelial cells, Cell. Signal., 14, 211, 2002.
148. Mihm, S. et al., Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives, AIDS, 5, 497, 1991.
149. Gosset, P. et al., Thiol regulation of the production of TNF-alpha, IL-6 and IL-8 by human alveolar macrophages, Eur. Respir. J., 14, 98, 1999.
150. Pajonk, F. et al., N-acetyl-L-cysteine inhibits 26s proteasome function: implications for effects on NF-kappa B activation, Free Radic. Biol. Med., 32, 536, 2002.
151. Peristeris, P. et al., N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production, Cell. Immunol., 140, 390, 1992.
152. Zhang, H. et al., Protective effects of N-acetyl-L-cysteine in endotoxemia, Am. J. Physiol., 266, H1746, 1994.
153. Bakker, J. et al., Effects of N-acetyl-cysteine in endotoxic shock, J. Crit. Care, 9, 236, 1994.
154. Spapen H., et al., Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest, 113, 1616, 1998.
155. Grimble, R.F. et al., Cysteine and glycine supplementation modulate the metabolic response to tumor necrosis factor alpha in rats fed a low protein diet, J. Nutr., 122, 2066, 1992.
156. Abdih, H. et al., Taurine prevents interleukin-2-induced acute lung injury in rats, Eur. Surg. Res., 32, 347, 2000.
157. Schmidt, H. et al., N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo, Crit. Care Med., 25, 858, 1997.
158. Leff, J.A. et al., Postinsult treatment with N-acetyl-L-cysteine decreases IL-1-induced neutrophil influx and lung leak in rats, Am. J. Physiol., 265, L501, 1993.
159. Villa, P. et al., Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defense, J. Infect. Dis., 185, 1115, 2002.
160. Kalebic, T. et al., Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine, Proc. Natl. Acad. Sci. U.S.A., 88, 986, 1991.
161. Breitkreutz, R. et al., Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials, J. Mol. Med., 78, 55, 2000.
162. Groeneveld, A.B.J. et al., Effects of N-acetylcysteine and terbutaline treatment on hemodynamics and regional albumin extravasation in porcine septic shock, Circ. Shock, 30, 185, 1990.
163. Jepsen, S. et al., Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study, Crit. Care Med., 20, 918, 1992.
164. Molnar, Z. et al., The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients, Intensive Care Med., 24, 230, 1998.